opioids

The impact of opioid agonist treatment on antipsychotic adherence among justice-involved patients in British Columbia

Substance dependence and mental illness frequently co-occur, presenting challenges to treatment providers and increasing the likelihood of suicide, drug overdose, and criminal justice involvement. Assessment and treatment of concurrent disorders (CD) have been identified by police, health professionals, and the Auditor General as urgent priorities in BC, and leadership in the treatment of CD is integral to the mandate of the Provincial Health Services Authority. 

Primary Investigator: 
Award Type: 
Year: 
2018

Optimizing care for opioid use disorder in British Columbia

British Columbia is facing an unprecedented and escalating opioid crisis, underscoring the urgent need for innovative science-driven solutions. There is critical implementation gap of evidence-based care for opioid use disorder (OUD), this research will seek to narrow this gap.

First, Dr. Socias will seek to advance the implementation of evidence-base treatments for OUD, by leading a series of ongoing and planned clinical trials evaluating innovative and promising models of care (e.g., take-home strategies) and alternate treatment options (e.g., slow-release oral morphine).

Primary Investigator: 
Award Type: 
Year: 
2018
Partners: 

Responding to the dual epidemics of hepatitis C and addiction in British Columbia

In British Columbia (BC), it is estimated that 78,000 people are living with hepatitis C virus (HCV), most of whom do not even know they have the disease. If left untreated, HCV can cause serious harm, including liver cancer and death. People who inject drugs (PWID) are at elevated risk of HCV infection given their exposure to various individual and environmental circumstances, such as their ongoing addiction and barriers to accessing health care.

Primary Investigator: 
Award Type: 
Year: 
2017
Health Category: 

Examining the addiction treatment and recovery trajectories of youth in British Columbia's Lower Mainland

Addiction treatment is critical to addressing the tremendous health and social harms experienced by street-involved youth (SY) with substance use disorders (SUD), including the current fentanyl overdose crisis.

Primary Investigator: 
Award Type: 
Year: 
2017
Health Category: 

Opioid addiction research program to improve prescribing practices and reduce overdose

Canada is amid an opioid crisis, with six or seven deaths a day due to opioid overdose. Prescription opioid misuse can also transition to illicit opiate and intravenous drug use, substantially increasing the risk for overdose and blood-borne infections. Rates of overdose death due to counterfeit fentanyl have also risen and represent a growing crisis in most regions in Canada, with British Columbia (BC) being particularly hard hit. Half of the 800 anticipated overdose deaths for 2016 in BC are expected to involve fentanyl.

Dr. Fairbairn's research will:

Primary Investigator: 
Award Type: 
Year: 
2017
Partners: 
Health Category: 

Addressing morbidity, mortality and health care costs among patients evaluated for addiction care in acute care settings

Substance use disorders account for a significant burden of disease among Canadians and place an enormous burden on the acute care system. The annual cost of harms associated with substance use in Canada is estimated to be approximately $40 billion, with health care being the single largest contributor. In British Columbia (BC) there is clear urgency to address this challenge, given the recent steady increase in hospitalization rates due to substance use and the unprecedented number of drug overdose deaths prompting the recent declaration of a public health emergency.

Primary Investigator: 
Year: 
2017
Health Category: 

Socio-economic risk environments and health among people who use drugs in British Columbia

Socio-economic well-being, which encompasses safe and sufficient income generating activity as well as adequate material resources, is intrinsically linked to health. Among marginalized people who use drugs (PWUD) who are living with or at risk of HIV/AIDS infection, socio-economic well-being is often precarious. However, the socio-economic risk environment of PWUD and its negative health impacts have not been fully examined.

Primary Investigator: 
Award Type: 
Year: 
2014
Subscribe to RSS - opioids